IllnessThyroid carcinoma, susceptibility
Summary
A panel containing 1 guideline-curated gene, furthermore 4 core candidate genes and altogether 10 curated genes for the comprehensive analysis of the genetic susceptibility Thyroid carcinomas
30,2 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS + SNP
[Sanger]
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
CDKN1B | 597 | NM_004064.5 | AD, Sus | |
PRKAR1A | 1146 | NM_002734.5 | AD, Sus | |
PTEN | 1212 | NM_000314.8 | AD | |
RET | 3345 | NM_020975.6 | AD, Sus | |
WRN | 4299 | NM_000553.6 | AR, Sus | |
APC | 8532 | NM_000038.6 | AD | |
DICER1 | 5769 | NM_177438.3 | AD | |
MUTYH | 1650 | NM_001128425.2 | AR, Sus | |
NKX2-1 | 1206 | NM_001079668.3 | AD | |
NTRK1 | 2373 | NM_001012331.2 | AD, Sus |
Informations about the disease
Although only about 5% of thyroid cancer cases are familial, thyroid cancer shows high heredity (compared to other cancers). Genetic predisposition syndromes account for about 5-15% of non-medullary thyroid cancer cases. Thyroid cancer develops in up to 12% of patients with familial adenomatosis polyposis and in at least 10% of people with Cowden's syndrome. Since genetic predisposition or susceptibility exclusively represents an increased probability of developing thyroid cancer based on a person's genetic predisposition, an unremarkable genetic finding does not mean that a suspected clinical diagnosis can be ruled out.
- Alias: Schilddrüsen-Karzinom, Prädisposition
- Alias: Thyroid cancer pertinent cancer susceptibility
- Allelic: Adenoma, periampullary, somatic (APC)
- Allelic: Adenomas, multiple colorectal (MUTYH)
- Allelic: Brain tumor-polyposis syndrome 2 (APC)
- Allelic: Chorea, hereditary benign (NKX2-1)
- Allelic: Choreoathetosis, hypothyroidism + neonatal respiratory distress (NKX2-1)
- Allelic: Colorectal cancer, somatic (APC)
- Allelic: Desmoid disease, hereditary (APC)
- Allelic: GLOW syndrome, somatic mosaic (DICER1)
- Allelic: Gardner syndrome (APC)
- Allelic: Gastric adenocarcinoma + proximal polyposis of the stomach (APC)
- Allelic: Gastric cancer, somatic (APC)
- Allelic: Gastric cancer, somatic (MUTYH)
- Allelic: Glioma susceptibility 2 (PTEN)
- Allelic: Hepatoblastoma, somatic (APC)
- Allelic: Hirschsprung disease, protection against/susceptibility to, 1 (RET)
- Allelic: Insensitivity to pain, congenital, with anhidrosis (NTRK1)
- Allelic: Macrocephaly/autism syndrome (PTEN)
- Allelic: Meningioma (PTEN)
- Allelic: Myxoma, intracardiac (PRKAR1A)
- Allelic: Neuroblastoma, susceptibility to, 3 (ALK-fusion)
- Allelic: Pheochromocytoma (RET)
- Allelic: Pigmented nodular adrenocortical disease, primary, 1 (PRKAR1A)
- Allelic: Pleuropulmonary blastoma (DICER1)
- Allelic: Prostate cancer, somatic (PTEN)
- Allelic: Rhabdomyosarcoma, embryonal, 2 (DICER1)
- Adenoma, periampullary, somatic (APC)
- Adenomatous polyposis coli (APC)
- Carney complex, type 1 (PRKAR1A)
- Cowden syndrome 1 (PTEN)
- Goiter, multinodular 1, with/-out Sertoli-Leydig cell tumors (DICER1)
- Lhermitte-Duclos syndrome (PTEN)
- Medullary thyroid carcinoma (RET)
- Multiple endocrine neoplasia IIA (RET)
- Multiple endocrine neoplasia IIA + IIB (RET)
- Multiple endocrine neoplasia, type IV (CDKN1B)
- Thyroid cancer, [guideline] (ALK-fusion)
- Thyroid cancer, nonmedullary, 1 (NKX2-1)
- Werner syndrome (WRN)
- AD
- AR
- Sus
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
No text defined